✦ LIBER ✦

Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors

✍ Scribed by Gert Jan Fleuren; Marius Nap; Jan G. Aalders; J. Baptist Trimbos; Henk W. A. de Bruijn

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 582 KB
Volume: 60
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19871115)60:10<2437::aid-cncr2820601015>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Color Doppler ultrasonography and serum

Color Doppler ultrasonography and serum CA 125 in the differentiation of benign and malignant ovarian tumors

✍ Cheng-Yang Chou; Chiung Hsin Chang; Bor-Lin Yao; Hong-Chang Kuo 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

## Abstract Color Doppler ultrasonography and serum CA 125 were used to evaluate 114 adnexal tumors prior to surgery. Six patients were excluded from this study because of ovarian cancer, borderline ovarian malignancy, and tubal gestation. A total of 108 patients were eligible: 83 patients with ben

Association between serum levels of solu

Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy : A Gynecologic Oncology Group study

✍ Robert A. Burger; Kathleen M. Darcy; Philip J. DiSaia; Bradley J. Monk; Elizabet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFR‐I) and II (sTNFR‐II), alone or in combination with CA 125, were associated with clinicopathologic characteristics

Lipoprotein(a) and CA125 levels in the p

Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease

✍ Annette C. Kuesel; Thérèse Kroft; Michel Préfontaine; Ian C. P. Smith 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 690 KB

## Abstract Elevated plasma levels of apolipoprotein (a) have been reported earlier in cancer patients. In order to investigate the potential of apolipoprotein(a) as an ovarian tumour marker, plasma apolipoprotein(a) and CA125 levels were measured in healthy women and women with benign or malignant

Serum CA 125 is of clinical value in the

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma : Correlation with tumor parameters and disease activity

✍ Ikram A. Burney; Tariq Siddiqui; Imran Siddiqui 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 3 views

W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni

Serum CA 125 is of clinical value in the

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma : Correlation with tumor parameters and disease activity

✍ Mario Lazzarino; Ester Orlandi; Catherine Klersy; Cesare Astori; Ercole Brusamol 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 3 views

## Background: Ca 125 is a glycoprotein produced by epithelial ovarian tumors and by mesothelial cells; its levels also have been shown to be elevated in patients with non-hodgkin's lymphoma (nhl). ## Methods: The authors evaluated serum ca 125 levels in patients with nhl to elucidate the frequen

Adenocarcinoma of the uterine cervix. Pr

Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum ca 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics

✍ Jitze M. Duk; Henk W. A. De Bruijn; Klaas H. Groenier; Gert Jan Fleuren; Jan G. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 807 KB